Haspin-IN-3

CAS No. 2416569-95-2

Haspin-IN-3( —— )

Catalog No. M35430 CAS No. 2416569-95-2

Haspin-IN-3 is a potent haspin inhibitor with an IC50 of 14 nM.Haspin-IN-3 has anticancer activity.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 91 In Stock
5MG 170 In Stock
10MG 275 In Stock
25MG 454 In Stock
50MG 678 In Stock
100MG 888 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Haspin-IN-3
  • Note
    Research use only, not for human use.
  • Brief Description
    Haspin-IN-3 is a potent haspin inhibitor with an IC50 of 14 nM.Haspin-IN-3 has anticancer activity.
  • Description
    Haspin-IN-3 (compound 8l) is a potent haspin inhibitor with IC50 of 14 nM. Haspin-IN-3 has anticancer effects.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Haspin Kinase
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2416569-95-2
  • Formula Weight
    278.26
  • Molecular Formula
    C16H10N2O3
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 25 mg/mL (89.84 mM; Ultrasonic (<60°C)
  • SMILES
    Oc1ccc2C(=O)\C(Oc2c1)=C\c1c[nH]c2ncccc12
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Malikotsi A Qhobosheane, et al. Synthesis and evaluation of 7-azaindole derivatives bearing benzocycloalkanone motifs as protein kinase inhibitors. Bioorg Med Chem. 2020 Jun 1;28(11):115468. ?
molnova catalog
related products
  • Saikosaponin H

    Saikosaponin H is a natural product from Bupleurum chinense.

  • IMS2186

    IMS2186 is a reagent with activity of antichoroidal neovascularization (CNV). IMS2186 could arrest cancer cell cycle in G2/M phase, result in exerting anti-proliferation and anti-angiogenesis effects.

  • Pristinamycin IA

    Pristinamycin IA is a substrate for the P-glycoprotein and a cyclo-peptidic macrolactone antibiotic.